{"id":1372,"date":"2016-09-22T08:05:58","date_gmt":"2016-09-22T07:05:58","guid":{"rendered":"http:\/\/www.soshepatites.org\/plateforme\/?page_id=1372"},"modified":"2017-12-08T12:17:21","modified_gmt":"2017-12-08T11:17:21","slug":"fibrometre","status":"publish","type":"page","link":"https:\/\/soshepatites.org\/plateforme\/hepatite-b\/suivi-et-analyses\/fibrometre\/","title":{"rendered":"Fibrom\u00e8tre"},"content":{"rendered":"<p><strong>Combinaison de 9 marqueurs sanguins ajust\u00e9s sur le sexe et l\u2019\u00e2ge (1)<\/strong><\/p>\n<ul>\n<li>num\u00e9ration plaquettaire<\/li>\n<li>taux de prothrombine (TP)<\/li>\n<li>aspartate amino-transf\u00e9rase<\/li>\n<li>a2-macroglobuline<\/li>\n<li>bilirubine totale<\/li>\n<li>ASAT\/ALAT<\/li>\n<li>acide hyaluronique<\/li>\n<li>ur\u00e9e<\/li>\n<li>\u03b3GT<\/li>\n<\/ul>\n<p>Score de 0 \u00e0 1 exprimant la probabilit\u00e9 d\u2019avoir une fibrose cliniquement significative (\u2265 F2) (1)<\/p>\n<p style=\"text-align: center;\"><strong>Conversion des valeurs num\u00e9riques du FibroMetre V\u00ae par rapport au score invasif de fibrose du foie METAVIR (1)<\/strong><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-522 size-large aligncenter\" src=\"http:\/\/www.soshepatites.org\/plateforme\/wp-content\/uploads\/2016\/01\/Capture-d%E2%80%99e%CC%81cran-2016-01-24-a%CC%80-20.11.30-1024x534.png\" sizes=\"auto, (max-width: 604px) 100vw, 604px\" srcset=\"http:\/\/www.soshepatites.org\/plateforme\/wp-content\/uploads\/2016\/01\/Capture-d\u2019e\u0301cran-2016-01-24-a\u0300-20.11.30-300x156.png 300w, http:\/\/www.soshepatites.org\/plateforme\/wp-content\/uploads\/2016\/01\/Capture-d\u2019e\u0301cran-2016-01-24-a\u0300-20.11.30-768x400.png 768w, http:\/\/www.soshepatites.org\/plateforme\/wp-content\/uploads\/2016\/01\/Capture-d\u2019e\u0301cran-2016-01-24-a\u0300-20.11.30-1024x534.png 1024w, http:\/\/www.soshepatites.org\/plateforme\/wp-content\/uploads\/2016\/01\/Capture-d\u2019e\u0301cran-2016-01-24-a\u0300-20.11.30-90x47.png 90w, http:\/\/www.soshepatites.org\/plateforme\/wp-content\/uploads\/2016\/01\/Capture-d\u2019e\u0301cran-2016-01-24-a\u0300-20.11.30.png 1262w\" alt=\"Capture d\u2019e\u0301cran 2016-01-24 a\u0300 20.11.30\" width=\"604\" height=\"315\" \/><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-533 size-full\" src=\"http:\/\/www.soshepatites.org\/plateforme\/wp-content\/uploads\/2016\/01\/fibrometre.jpg\" sizes=\"auto, (max-width: 600px) 100vw, 600px\" srcset=\"http:\/\/www.soshepatites.org\/plateforme\/wp-content\/uploads\/2016\/01\/fibrometre-300x163.jpg 300w, http:\/\/www.soshepatites.org\/plateforme\/wp-content\/uploads\/2016\/01\/fibrometre.jpg 600w\" alt=\"fibrometre\" width=\"600\" height=\"325\" \/><\/p>\n<h6 class=\"p1\">(1) Haute Autorit\u00e9 de Sant\u00e9. M\u00e9thodes non invasives de la mesure de la fibrose h\u00e9patique\/Diagnostic de la cirrhose non compliqu\u00e9e. HAS 2008.<\/h6>\n<h6 class=\"p1\">(2) Haute Autorit\u00e9 de Sant\u00e9. M\u00e9thodes non invasives d\u2019\u00e9valuation de la fibrose\/cirrhose h\u00e9patique. HAS 2006.<\/h6>\n<h6 class=\"p1\">(3) Dhumeaux D et al. \u00c9valuation de la fibrose h\u00e9patique chez les patients atteints d\u2019h\u00e9patites B et C. In : Prise en charge des personnes infect\u00e9es par les virus de l\u2019h\u00e9patite B ou de l\u2019h\u00e9patite C. Recommandations du groupe d\u2019experts et sous l\u2019\u00e9gide de l\u2019ANRS et de l\u2019AFEF. Paris:Ed. EDP sciences.Rapport 2014;p141-167.<\/h6>\n<h6 class=\"p1\">(4) Vergniol A et de Ledinghen V. Diagnostic non invasif de la fibrose h\u00e9patique : modalit\u00e9s pratiques d\u2019utilisation des marqueurs sanguins et du FibroScan. Gastroenterol Clin Biol 2009;33:334-344.<\/h6>\n<h6 class=\"p1\">(5) Balian A et Barri-Ova N. Nouveaux moyens diagnostiques de la cirrhose. R\u00e9animation 2007;16:563-567.<\/h6>\n<h6 class=\"p1\">(6) Castera L. Int\u00e9r\u00eat de l\u2019\u00e9lastom\u00e9trie (FibroScan\u00ae) pour l\u2019\u00e9valuation non invasive de la fibrose h\u00e9patique. Gastroenterol Clin Biol 2007;31:524-530.<\/h6>\n<h6 class=\"p1\">(7) Halfon P, et al. Int\u00e9r\u00eat et limites des m\u00e9thodes non invasives de pr\u00e9diction de la fibrose h\u00e9patique au cours de l\u2019h\u00e9patite C : une alternative \u00e0 la biopsie h\u00e9patique. Presse Med 2007;36:457-466.<\/h6>\n<h6 class=\"p1\">(8) Halfon P. Les limites du Fibrotest dans la prise en charge de l\u2019h\u00e9patite C. Gastroenterol Clin Biol 2006;30:117-120.<\/h6>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Combinaison de 9 marqueurs sanguins ajust\u00e9s sur le sexe et l\u2019\u00e2ge (1) num\u00e9ration plaquettaire taux de prothrombine (TP) aspartate amino-transf\u00e9rase a2-macroglobuline bilirubine totale ASAT\/ALAT acide hyaluronique ur\u00e9e \u03b3GT Score de 0 \u00e0 1 exprimant la probabilit\u00e9 d\u2019avoir une fibrose cliniquement significative (\u2265 F2) (1) Conversion des valeurs num\u00e9riques du FibroMetre V\u00ae par rapport au score &hellip; <a href=\"https:\/\/soshepatites.org\/plateforme\/hepatite-b\/suivi-et-analyses\/fibrometre\/\" class=\"more-link\">Continuer la lecture de <span class=\"screen-reader-text\">Fibrom\u00e8tre<\/span> <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1362,"menu_order":5,"comment_status":"closed","ping_status":"closed","template":"page-templates\/pf2-page-sans-article.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1372","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Fibrom\u00e8tre - nous sommes H\u00c9PATANTS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/soshepatites.org\/plateforme\/hepatite-b\/suivi-et-analyses\/fibrometre\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fibrom\u00e8tre - nous sommes H\u00c9PATANTS\" \/>\n<meta property=\"og:description\" content=\"Combinaison de 9 marqueurs sanguins ajust\u00e9s sur le sexe et l\u2019\u00e2ge (1) num\u00e9ration plaquettaire taux de prothrombine (TP) aspartate amino-transf\u00e9rase a2-macroglobuline bilirubine totale ASAT\/ALAT acide hyaluronique ur\u00e9e \u03b3GT Score de 0 \u00e0 1 exprimant la probabilit\u00e9 d\u2019avoir une fibrose cliniquement significative (\u2265 F2) (1) Conversion des valeurs num\u00e9riques du FibroMetre V\u00ae par rapport au score &hellip; Continuer la lecture de Fibrom\u00e8tre &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/soshepatites.org\/plateforme\/hepatite-b\/suivi-et-analyses\/fibrometre\/\" \/>\n<meta property=\"og:site_name\" content=\"nous sommes H\u00c9PATANTS\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SOS.hepatites.Federation\/\" \/>\n<meta property=\"article:modified_time\" content=\"2017-12-08T11:17:21+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.soshepatites.org\/plateforme\/wp-content\/uploads\/2016\/01\/Capture-d%E2%80%99e%CC%81cran-2016-01-24-a%CC%80-20.11.30-1024x534.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@SOS_hepatites\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/hepatite-b\\\/suivi-et-analyses\\\/fibrometre\\\/\",\"url\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/hepatite-b\\\/suivi-et-analyses\\\/fibrometre\\\/\",\"name\":\"Fibrom\u00e8tre - nous sommes H\u00c9PATANTS\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/hepatite-b\\\/suivi-et-analyses\\\/fibrometre\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/hepatite-b\\\/suivi-et-analyses\\\/fibrometre\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.soshepatites.org\\\/plateforme\\\/wp-content\\\/uploads\\\/2016\\\/01\\\/Capture-d%E2%80%99e%CC%81cran-2016-01-24-a%CC%80-20.11.30-1024x534.png\",\"datePublished\":\"2016-09-22T07:05:58+00:00\",\"dateModified\":\"2017-12-08T11:17:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/hepatite-b\\\/suivi-et-analyses\\\/fibrometre\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/hepatite-b\\\/suivi-et-analyses\\\/fibrometre\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/hepatite-b\\\/suivi-et-analyses\\\/fibrometre\\\/#primaryimage\",\"url\":\"http:\\\/\\\/www.soshepatites.org\\\/plateforme\\\/wp-content\\\/uploads\\\/2016\\\/01\\\/Capture-d%E2%80%99e%CC%81cran-2016-01-24-a%CC%80-20.11.30-1024x534.png\",\"contentUrl\":\"http:\\\/\\\/www.soshepatites.org\\\/plateforme\\\/wp-content\\\/uploads\\\/2016\\\/01\\\/Capture-d%E2%80%99e%CC%81cran-2016-01-24-a%CC%80-20.11.30-1024x534.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/hepatite-b\\\/suivi-et-analyses\\\/fibrometre\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"H\u00e9patite B\",\"item\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/hepatite-b\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Suivi et analyses\",\"item\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/hepatite-b\\\/suivi-et-analyses\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Fibrom\u00e8tre\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/#website\",\"url\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/\",\"name\":\"nous sommes H\u00c9PATANTS\",\"description\":\"Plateforme d&#039;information  sur les maladies du foie\",\"publisher\":{\"@id\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/#organization\",\"name\":\"SOS HEPATITES FEDERATION\",\"url\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/wp-content\\\/uploads\\\/2016\\\/01\\\/logo-sos-hepatite.png\",\"contentUrl\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/wp-content\\\/uploads\\\/2016\\\/01\\\/logo-sos-hepatite.png\",\"width\":220,\"height\":56,\"caption\":\"SOS HEPATITES FEDERATION\"},\"image\":{\"@id\":\"https:\\\/\\\/soshepatites.org\\\/plateforme\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/SOS.hepatites.Federation\\\/\",\"https:\\\/\\\/x.com\\\/SOS_hepatites\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/soshepatitesfd\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fibrom\u00e8tre - nous sommes H\u00c9PATANTS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/soshepatites.org\/plateforme\/hepatite-b\/suivi-et-analyses\/fibrometre\/","og_locale":"fr_FR","og_type":"article","og_title":"Fibrom\u00e8tre - nous sommes H\u00c9PATANTS","og_description":"Combinaison de 9 marqueurs sanguins ajust\u00e9s sur le sexe et l\u2019\u00e2ge (1) num\u00e9ration plaquettaire taux de prothrombine (TP) aspartate amino-transf\u00e9rase a2-macroglobuline bilirubine totale ASAT\/ALAT acide hyaluronique ur\u00e9e \u03b3GT Score de 0 \u00e0 1 exprimant la probabilit\u00e9 d\u2019avoir une fibrose cliniquement significative (\u2265 F2) (1) Conversion des valeurs num\u00e9riques du FibroMetre V\u00ae par rapport au score &hellip; Continuer la lecture de Fibrom\u00e8tre &rarr;","og_url":"https:\/\/soshepatites.org\/plateforme\/hepatite-b\/suivi-et-analyses\/fibrometre\/","og_site_name":"nous sommes H\u00c9PATANTS","article_publisher":"https:\/\/www.facebook.com\/SOS.hepatites.Federation\/","article_modified_time":"2017-12-08T11:17:21+00:00","og_image":[{"url":"http:\/\/www.soshepatites.org\/plateforme\/wp-content\/uploads\/2016\/01\/Capture-d%E2%80%99e%CC%81cran-2016-01-24-a%CC%80-20.11.30-1024x534.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@SOS_hepatites","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/soshepatites.org\/plateforme\/hepatite-b\/suivi-et-analyses\/fibrometre\/","url":"https:\/\/soshepatites.org\/plateforme\/hepatite-b\/suivi-et-analyses\/fibrometre\/","name":"Fibrom\u00e8tre - nous sommes H\u00c9PATANTS","isPartOf":{"@id":"https:\/\/soshepatites.org\/plateforme\/#website"},"primaryImageOfPage":{"@id":"https:\/\/soshepatites.org\/plateforme\/hepatite-b\/suivi-et-analyses\/fibrometre\/#primaryimage"},"image":{"@id":"https:\/\/soshepatites.org\/plateforme\/hepatite-b\/suivi-et-analyses\/fibrometre\/#primaryimage"},"thumbnailUrl":"http:\/\/www.soshepatites.org\/plateforme\/wp-content\/uploads\/2016\/01\/Capture-d%E2%80%99e%CC%81cran-2016-01-24-a%CC%80-20.11.30-1024x534.png","datePublished":"2016-09-22T07:05:58+00:00","dateModified":"2017-12-08T11:17:21+00:00","breadcrumb":{"@id":"https:\/\/soshepatites.org\/plateforme\/hepatite-b\/suivi-et-analyses\/fibrometre\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/soshepatites.org\/plateforme\/hepatite-b\/suivi-et-analyses\/fibrometre\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/soshepatites.org\/plateforme\/hepatite-b\/suivi-et-analyses\/fibrometre\/#primaryimage","url":"http:\/\/www.soshepatites.org\/plateforme\/wp-content\/uploads\/2016\/01\/Capture-d%E2%80%99e%CC%81cran-2016-01-24-a%CC%80-20.11.30-1024x534.png","contentUrl":"http:\/\/www.soshepatites.org\/plateforme\/wp-content\/uploads\/2016\/01\/Capture-d%E2%80%99e%CC%81cran-2016-01-24-a%CC%80-20.11.30-1024x534.png"},{"@type":"BreadcrumbList","@id":"https:\/\/soshepatites.org\/plateforme\/hepatite-b\/suivi-et-analyses\/fibrometre\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/soshepatites.org\/plateforme\/"},{"@type":"ListItem","position":2,"name":"H\u00e9patite B","item":"https:\/\/soshepatites.org\/plateforme\/hepatite-b\/"},{"@type":"ListItem","position":3,"name":"Suivi et analyses","item":"https:\/\/soshepatites.org\/plateforme\/hepatite-b\/suivi-et-analyses\/"},{"@type":"ListItem","position":4,"name":"Fibrom\u00e8tre"}]},{"@type":"WebSite","@id":"https:\/\/soshepatites.org\/plateforme\/#website","url":"https:\/\/soshepatites.org\/plateforme\/","name":"nous sommes H\u00c9PATANTS","description":"Plateforme d&#039;information  sur les maladies du foie","publisher":{"@id":"https:\/\/soshepatites.org\/plateforme\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/soshepatites.org\/plateforme\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/soshepatites.org\/plateforme\/#organization","name":"SOS HEPATITES FEDERATION","url":"https:\/\/soshepatites.org\/plateforme\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/soshepatites.org\/plateforme\/#\/schema\/logo\/image\/","url":"https:\/\/soshepatites.org\/plateforme\/wp-content\/uploads\/2016\/01\/logo-sos-hepatite.png","contentUrl":"https:\/\/soshepatites.org\/plateforme\/wp-content\/uploads\/2016\/01\/logo-sos-hepatite.png","width":220,"height":56,"caption":"SOS HEPATITES FEDERATION"},"image":{"@id":"https:\/\/soshepatites.org\/plateforme\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SOS.hepatites.Federation\/","https:\/\/x.com\/SOS_hepatites","https:\/\/www.youtube.com\/user\/soshepatitesfd"]}]}},"_links":{"self":[{"href":"https:\/\/soshepatites.org\/plateforme\/wp-json\/wp\/v2\/pages\/1372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/soshepatites.org\/plateforme\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/soshepatites.org\/plateforme\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/soshepatites.org\/plateforme\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/soshepatites.org\/plateforme\/wp-json\/wp\/v2\/comments?post=1372"}],"version-history":[{"count":5,"href":"https:\/\/soshepatites.org\/plateforme\/wp-json\/wp\/v2\/pages\/1372\/revisions"}],"predecessor-version":[{"id":1983,"href":"https:\/\/soshepatites.org\/plateforme\/wp-json\/wp\/v2\/pages\/1372\/revisions\/1983"}],"up":[{"embeddable":true,"href":"https:\/\/soshepatites.org\/plateforme\/wp-json\/wp\/v2\/pages\/1362"}],"wp:attachment":[{"href":"https:\/\/soshepatites.org\/plateforme\/wp-json\/wp\/v2\/media?parent=1372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}